Klaviyo Inc has a consensus price target of $31.47 based on the ratings of 35 analysis. The 3 most-recent analyst ratings were released by Barclays, Needham, and Cantor Fitzgerald on June 12, 2024, May 17, 2024, and May 9, 2024, respectively. With an average price target of $33.33 between Barclays, Needham, and Cantor Fitzgerald, there's an implied 33.33% upside for Klaviyo Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/12/2024 | Buy Now | 16% | Barclays | Raimo Lenschow | $25 → $29 | Upgrade | Equal-Weight → Overweight | Get Alert |
05/17/2024 | Buy Now | 60% | Needham | Scott Berg | → $40 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 24% | Cantor Fitzgerald | Brett Knoblauch | → $31 | Reiterates | Overweight → Overweight | Get Alert |
05/09/2024 | Buy Now | 60% | Needham | Scott Berg | → $40 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 28% | Canaccord Genuity | David Hynes | $37 → $32 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | — | Barclays | Raimo Lenschow | $32 → $25 | Maintains | Equal-Weight | Get Alert |
05/09/2024 | Buy Now | 40% | Mizuho | Siti Panigrahi | $40 → $35 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 40% | Baird | Rob Oliver | $40 → $35 | Maintains | Outperform | Get Alert |
04/17/2024 | Buy Now | 28% | Morgan Stanley | Elizabeth Porter | $37 → $32 | Maintains | Equal-Weight | Get Alert |
04/16/2024 | Buy Now | 24% | Cantor Fitzgerald | Brett Knoblauch | → $31 | Initiates | → Overweight | Get Alert |
04/02/2024 | Buy Now | 20% | Scotiabank | Nick Altmann | → $30 | Initiates | → Sector Perform | Get Alert |
03/21/2024 | Buy Now | — | Keybanc | Jason Ader | — | Initiates | → Sector Weight | Get Alert |
03/20/2024 | Buy Now | 40% | FBN Securities | Shebly Seyrafi | → $35 | Initiates | → Outperform | Get Alert |
03/01/2024 | Buy Now | 60% | Needham | Scott Berg | → $40 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 48% | Morgan Stanley | Elizabeth Porter | $38 → $37 | Maintains | Equal-Weight | Get Alert |
02/28/2024 | Buy Now | 60% | Needham | Scott Berg | → $40 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 52% | Piper Sandler | Brent Bracelin | → $38 | Reiterates | Overweight → Overweight | Get Alert |
02/05/2024 | Buy Now | 44% | Goldman Sachs | Gabriela Borges | → $36 | Upgrade | Neutral → Buy | Get Alert |
01/24/2024 | Buy Now | 52% | Piper Sandler | Brent Bracelin | → $38 | Reiterates | Overweight → Overweight | Get Alert |
01/12/2024 | Buy Now | 28% | Barclays | Raimo Lenschow | $37 → $32 | Maintains | Equal-Weight | Get Alert |
12/19/2023 | Buy Now | 60% | Needham | Scott Berg | → $40 | Reiterates | Buy → Buy | Get Alert |
12/08/2023 | Buy Now | 60% | Loop Capital | Yun Kim | → $40 | Initiates | → Buy | Get Alert |
11/08/2023 | Buy Now | 52% | Piper Sandler | Brent Bracelin | → $38 | Reiterates | Overweight → Overweight | Get Alert |
10/16/2023 | Buy Now | 52% | Citigroup | Tyler Radke | → $38 | Initiates | → Neutral | Get Alert |
10/16/2023 | Buy Now | 48% | Canaccord Genuity | David Hynes | → $37 | Initiates | → Buy | Get Alert |
10/16/2023 | Buy Now | 60% | Mizuho | Siti Panigrahi | → $40 | Initiates | → Buy | Get Alert |
10/16/2023 | Buy Now | 68% | TD Cowen | Derrick Wood | → $42 | Initiates | → Outperform | Get Alert |
10/16/2023 | Buy Now | — | William Blair | Arjun Bhatia | — | Initiates | → Outperform | Get Alert |
10/16/2023 | Buy Now | 48% | Barclays | Raimo Lenschow | → $37 | Initiates | → Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 60% | Baird | Rob Oliver | → $40 | Initiates | → Outperform | Get Alert |
10/16/2023 | Buy Now | 60% | Needham | Scott Berg | → $40 | Initiates | → Buy | Get Alert |
10/16/2023 | Buy Now | 68% | Truist Securities | Terry Tillman | → $42 | Initiates | → Buy | Get Alert |
10/16/2023 | Buy Now | 52% | Morgan Stanley | Elizabeth Porter | → $38 | Initiates | → Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 44% | Goldman Sachs | Gabriela Borges | → $36 | Initiates | → Neutral | Get Alert |
10/16/2023 | Buy Now | 52% | Piper Sandler | Brent Bracelin | → $38 | Initiates | → Overweight | Get Alert |
The latest price target for Klaviyo (NYSE:KVYO) was reported by Barclays on June 12, 2024. The analyst firm set a price target for $29.00 expecting KVYO to rise to within 12 months (a possible 16.00% upside). 35 analyst firms have reported ratings in the last year.
The latest analyst rating for Klaviyo (NYSE:KVYO) was provided by Barclays, and Klaviyo upgraded their overweight rating.
The last upgrade for Klaviyo Inc happened on June 12, 2024 when Barclays raised their price target to $29. Barclays previously had an equal-weight for Klaviyo Inc.
There is no last downgrade for Klaviyo.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Klaviyo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Klaviyo was filed on June 12, 2024 so you should expect the next rating to be made available sometime around June 12, 2025.
While ratings are subjective and will change, the latest Klaviyo (KVYO) rating was a upgraded with a price target of $25.00 to $29.00. The current price Klaviyo (KVYO) is trading at is $25.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.